| Johnson
Matthey is hosting a visit to its Pharmaceutical Materials
and Autocatalyst businesses in the US for chemicals
stockbroking analysts during 16th and 17th September
2002. On 17th September, Chris Clark, Chief Executive
of Johnson Matthey, will be giving a brief update on
current trading. The main points of which are as follows:
Trading
in Johnson Matthey's second quarter is in line
with expectations. The progress of each of the
group's divisions is similar to the first quarter.
Catalysts & Chemicals
Division is achieving good growth with the autocatalyst
business continuing to benefit from the worldwide
introduction of our precision coating technology.
Precious Metals Division's profits are down on
last year reflecting lower average prices for platinum
group metals (pgm's) compared with last year and
subdued trading conditions in the pgm markets.
Colours & Coatings Division's profitability
has improved since the second half of last year
as the benefits of the rationalisation programme
announced in January come through. Pharmaceutical
Materials Division is achieving strong growth benefiting
from good sales of the new products launched at
the end of last year and good contributions from
Macfarlan Smith and Pharm-Eco.
The
US dollar has weakened significantly against sterling
in the last few months. This will have an impact
on the translation of the group's US profits into
sterling. Despite this adverse exchange translation
and the lower average pgm prices experienced in
the first half, the group still expects to deliver
growth in profit before tax, exceptional items
and goodwill amortisation for the six months to
30th September 2002 compared with the same period
of last year.
|
Enquiries:
Gavin
Anderson & Co
Howard
Lee
Will Swan
020 7554 1400
|